4
Trustees’ Annual Report for the period
From 01/04/2023 To 31/03/2024
Charity name: United Kingdom and Ireland Oesophagogastric Cancer Group
Charity registration number: 1198358
Objectives and Activities
| SORP reference | ||
|---|---|---|
| Summary of the purposes of the charity as set out in its governing document |
Para 1.17 | For the public benefit, the advancement of health and saving of lives by (but not limited to) the following means: a) providing a forum to share knowledge and for discussion about medical cases in the field of oncology; b) providing information and advice to those who work in the field of oncology about care and treatment of cancers, including but not limited to oesophageal and gastric cancer; and c) carrying out such other charitable activities as the trustees see fit from time to time which would improve the standard of care and treatment of oesophageal and gastric cancer patients and cancerpatientsgenerally. |
| Summary of the main activities in relation to those purposes for the public benefit, in particular, the activities, projects or services identified in the accounts. |
Para 1.17 and 1.19 |
• Provides education/advocacy/advice/information • Workshops, conferences, seminars and/or lectures • professional training |
| Statement confirming whether the trustees have had regard to the guidance issued by the Charity Commission on public benefit |
Para 1.18 | THE UKIOG Charity aims to improve outcomes for Oesophago gastric cancer patients by sharing of best practice, supporting research and facilitating training. All of these activities are aimed at ultimately improving the care of cancer patients and therefore are a benefit to the public. |
Additional information (optional) You may choose to include further statements where relevant about:
SORP reference UKIOG does not presently make grants. Para 1.38 Policy on grant making
| Policy on social investment including program related investment |
Para 1.38 | UKIOG does not carry out social investments. |
|---|---|---|
| Contribution made by volunteers |
Para 1.38 | The founders, steering group and committees are formed of volunteers who provide their time free of charge. The only payments made are to faculty / speakers to support their attendance at the face to face meetings. |
| Other |
Achievements and Performance
| SORP reference | ||
|---|---|---|
| Summary of the main achievements of the charity, identifying the difference the charity’s work has made to the circumstances of its beneficiaries and any wider benefits to society as a whole. |
Para 1.20 | The charity has successfully run 3 virtual National MDTs where complex cancer cases are discussed and then learnings from these cases disseminated. This has harmonised best practice and highlighted where centres are offering procedures or other treatments not on offer in other centres. This has directly led to the transfer of patients care to super specialist centres. We also ran our second face to face annual event meeting attended by 150 people from across all the healthcare professions who look after Oesophageal and gastric cancer patients. This meeting highlighted the latest areas of research and shared best practice in managing these complex patients. Feedback from this meeting was extremely positive with 97.3% of people stating they were highly satisfied with the event overall. We hosted our first UKIOG webinar which was attended by 190 people from across all the healthcare professions who look after Oesophageal and gastric cancer patients. Feedback from this meeting was extremely positive with 92% of people stating they would recommend the webinar to professional colleagues. |
Additional information (optional) You may choose to include further statements where relevant about:
We achieved our goals for this period.
| Achievements against objectives set |
Para 1.41 | |
|---|---|---|
| Performance of fundraising activities against objectives set |
Para 1.41 | We fund our activities via sponsorship from medical companies. This pays for the events and the remaining money is then available for other activities. |
| Investment performance against objectives |
Para 1.41 | N/A |
| Other |
Financial Review
| Financial Review | ||
|---|---|---|
| Review of the charity’s financial position at the end of the period |
Para 1.21 | We ended the financial period with a sum of £29,765. We have no other assets and no liabilities. |
| Statement explaining the policy for holding reserves stating why they are held |
Para 1.22 | We don’t aim to keep a reserve, but the sum left at the end of this financial year is to allow us to prepare for the subsequent years activities, cover secretarial support and to invest in a professional website to allow us to disseminate the training materials we have created. |
| Amount of reserves held | Para 1.22 | N/A |
| Reasons for holding zero reserves |
Para 1.22 | N/A |
| Details of fund materially in deficit |
Para 1.24 | N/A |
| Explanation of any uncertainties about the charity continuing as a going concern |
Para 1.23 | N/A |
| Additional information (optional) You may choose to include further statements |
Additional information (optional) You may choose to include further statements |
where relevant about: |
|---|---|---|
| The charity’s principal sources of funds (including any fundraising) |
Para 1.47 | Sponsorship from medical companies. |
| Investment policy and objectives including any social investment policy adopted |
Para 1.46 | N/A |
| A description of the principal risks facing the charity |
Para 1.46 | None at present. After the first sponsored events the sponsors have made it clear they are very happy to continue sponsoring more events. |
| Other |
Structure, Governance and Management
| Description of charity’s trusts: |
N/A | |
|---|---|---|
| Type of governing document (trust deed, royal charter) |
Para 1.25 | CIO Constitution. |
| How is the charity constituted? (e.g unincorporated association, CIO) |
Para 1.25 | CIO |
| Trustee selection methods including details of any constitutional provisions e.g. election to post or name of any person or body entitled to appoint one or more trustees |
Para 1.25 | The current three trustees were responsible for the creation of UKIOG and its formation as a charity. New trustees will be appointed as required by a process of self nomination and then voting by the steering committee and all the sub committees that form UKIOG |
Additional information (optional) You may choose to include further statements where relevant about:
| Policies and procedures adopted for the induction and training of trustees |
Para 1.51 | We will use the Charity Excellence Framework courses to trainee new trustees. |
|---|---|---|
| The charity’s organisational structure and any wider network with which the charity works |
Para 1.51 | The charity is formed of the three trustees, a steering committee and then a Research Committee. Additional committees will be set up of the course of 2024. |
| Relationship with any related parties |
Para 1.51 | None |
| Other |
Reference and Administrative details
| Charity name | United Kingdom and Ireland Oesophagogastric Cancer Group |
|---|---|
| Other name the charity uses | |
| Registered charitynumber | 1198358 |
| Charity’s principal address | Velindre Cancer Centre, Velindre Road, Whitchurch, Cardiff, CF14 2TL |
Names of the charity trustees who manage the charity
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 |
Trustee name | Office (if any) | Dates acted if not for whole **year ** |
Name of person (or body) entitled to appoint trustee (ifany) |
|---|---|---|---|---|
| Thomas Crosby | ||||
| Christopher Peters | ||||
| Elizabeth Smyth | ||||
– Corporate trustees names of the directors at the date the report was approved
Director name N/A
Name of trustees holding title to property belonging to the charity
| Trustee name | Dates acted if not for whole year | |
|---|---|---|
| None | ||
Funds held as custodian trustees on behalf of others
Description of the assets None held in this capacity Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets
Additional information (optional)
Names and addresses of advisers (Optional information)
| Names and addresses of advisers (Optional information) | Names and addresses of advisers (Optional information) | Names and addresses of advisers (Optional information) |
|---|---|---|
| Type of adviser Name Address |
||
| Name of chief executive or names of senior staff members (Optional information) | ||
Exemptions from disclosure
Reason for non-disclosure of key personnel details
N/A
Other optional information
N/A
Declarations
The trustees declare that they have approved the trustees’ report above.
Signed on behalf of the charity’s trustees
| Signature(s) Full name(s) Position (eg Secretary, Chair, etc) Date |
||
|---|---|---|
| Prof Thomas Crosby | ||
Trustee |
||
| 17.10.24 | ||
| 17.10.24 |
| Date | Description | Income Money IN | Expense Money OUT | Overall Balance |
|---|---|---|---|---|
| 05/04/2023 | Payment for website | £1.20 | £31,070.04 | |
| 02/05/2023 | Admin Payment for work carried out | £1,180 | £29,890.04 | |
| 09/05/2023 | Payment for website | £40.80 | £29,849.24 | |
| 23/05/2023 | Admin Payment for work carried out | £96 | £29,753.24 | |
| 07/06/2023 | Payment for website | £10.80 | £29,742.44 | |
| 14/06/2023 | Further invoice for Royal Society of Medicine for Event - Annual Meeting |
£2,000 | £27,742.44 | |
| 06/07/2023 | Payment for website | £10.80 | £27,731.64 | |
| 07/08/2023 | Payment for website | £10.80 | £27,720.84 | |
| 14/08/2023 | Further invoice for Royal Society of Medicine for Event - Annual Meeting |
£2,000 | £25,270.84 | |
| 06/09/2023 | Payment for website | £10.80 | £25,710.04 | |
| 06/10/2023 | Payment for website | £10.80 | £25,699.24 | |
| 07/11/2023 | Payment for website | £10.80 | £25,688.44 | |
| 06/12/2023 | Payment for website | £10.80 | £25,677.64 | |
| 13/12/2023 | Payment for development of new website - John Chipperfield |
£5,000 | £20,677.64 | |
| 18/12/2023 | Payment for development of new website - John Chipperfield |
£1,000 | £19,677.64 | |
| 04/01/2024 | Payment to Media 1 Productions for 2024 Annual Meeting |
£3,390 | £16,287.64 | |
| 05/01/2024 | Payment for website | £10.80 | £16,276.84 | |
| 05/02/2024 | Payment to Royal Society of Medicine for Event - Annual Meeting2024 |
£3,240 | £13,036.84 | |
| 07/02/2024 | Payment for website | £10.80 | £13,026.04 | |
| 23/02/2024 | Sponsorship from Amgen for Annual Meeting2024 |
£10,000 | £23,026.04 | |
| 01/03/2024 | Sponsorship from Servier for Annual Meeting2024 |
£1,500 | £24,526.04 | |
| 07/03/2024 | Payment for website | £10.80 | £24,515.24 |
| 18/03/2004 | Cook UK Sponsorship of Annual Meeting2024 |
£2,500 | £27,015.24 | |
|---|---|---|---|---|
| 18/03/2004 | Biohit Healthcare UK Sponsorship of Annual Meeting2024 |
£2,750 | £29,765.24 |
Total Current Assets 0 Total Current Liabilities 0